Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesA randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic NSCLC
Annals of Oncology, 10/19/09
Treat JA et al. – Paclitaxel–carboplatin is used as the standard regimen for patients with advanced or metastatic non-small-cell lung cancer (NSCLC). This trial was designed to compare gemcitabine + carboplatin or gemcitabine + paclitaxel to the standard regimen. Non-platinum and non-paclitaxel gemcitabine-containing doublets demonstrate similar overall survival and RR compared with the standard PC regimen. The treatment arms had distinct toxicity profiles.
Methods- 1135 chemonaive patients with stage IIIB or IV NSCLC
- Randomly allocated to receive gemcitabine 1000 mg/m2 on days 1 and 8 plus carboplatin area under concentration–time curve (AUC) 5.5 on day 1 (GC), gemcitabine 1000 mg/m2 on days 1 and 8 plus paclitaxel 200 mg/m2 on day 1 (GP), or paclitaxel 225 mg/m2 plus carboplatin AUC 6.0 on day 1 (PC)
- Stratification based on disease stage, baseline weight loss, and presence or absence of brain metastases
- Cycles repeated every 21 days for up to 6 cycles or disease progression
- Median survival (months) with GC 7.9 compared with 8.5 for GP and 8.7 for PC
- Response rates (RRs) as follows: GC, 25.3%; GP, 32.1%; and PC, 29.8%
- The GC arm associated with greaterincidence of grade 3 or 4 hematologic events but lower rate of neurotoxicity and alopecia when compared with GP and PC
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Underutilization of radiotherapy for lung cancer in New South Wales, Australia
Cancer, 12/14/09
Characterizing the Clinical Relevance of an Embryonic Stem Cell Phenotype in Lung Adenocarcinoma
Clinical Cancer Research, 12/14/09
Differential Thymidylate Synthase Expression in Different Variants of Large-Cell Carcinoma of the Lung
Clinical Cancer Research, 12/14/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Targeted proteasome inhibition by Velcade induces apoptosis in human mesothelioma and breast cancer cell lines
Cancer Chemotherapy and Pharmacology, 12/14/09
Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol
Cancer, 12/14/09
Sponsor
Article Search
Sponsor
Sponsor